Bibliographie (2546)
RCT: Novavax vaccine is 49.4% effective against B.1.351 SARS-CoV-2 variant.
jeudi, 06 mai 2021 13:42 Écrit par Zouhair SouissiEfficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant – New England Journal of Medicine
The post RCT: Novavax vaccine is 49.4% effective against B.1.351 SARS-CoV-2 variant. appeared first on Links Medicus.
In shock move, US backs waiving patents on COVID vaccines. “The development from the Biden administration draws cheers from public health researchers and ire from drugmakers.”
jeudi, 06 mai 2021 13:42 Écrit par Zouhair SouissiIn shock move, US backs waiving patents on COVID vaccines – Nature See also: U.S. will back proposal to waive intellectual property rights and boost Covid-19 vaccine production – STAT AND Statement from the Executive Director of UNAIDS, Winnie Byanyima on the decision by the United States of America to support the TRIPS waiver for […]
The post In shock move, US backs waiving patents on COVID vaccines. “The development from the Biden administration draws cheers from public health researchers and ire from drugmakers.” appeared first on Links Medicus.
ATS Guideline: Nucleic acid–based testing for noninfluenza viral pathogens in adults with suspected community-acquired pneumonia – Testing should be considered only in patients with severe CAP and in immunocompromised patients
mercredi, 05 mai 2021 14:40 Écrit par Zouhair SouissiNucleic Acid–based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline News Release: New clinical practice guideline on community acquired pneumonia – American Thoracic Society
The post ATS Guideline: Nucleic acid–based testing for noninfluenza viral pathogens in adults with suspected community-acquired pneumonia – Testing should be considered only in patients with severe CAP and in immunocompromised patients appeared first on Links Medicus.
Perspective | We may never achieve long-term global herd immunity for COVID. But if we’re all vaccinated, we’ll be safe from the worst
mercredi, 05 mai 2021 14:40 Écrit par Zouhair SouissiWe may never achieve long-term global herd immunity for COVID. But if we’re all vaccinated, we’ll be safe from the worst – The Conversation See also: Reaching ‘Herd Immunity’ Is Unlikely in the U.S., Experts Now Believe – The New York Times (free registration required) AND We May Never Get to Herd Immunity – Think Global Health
The post Perspective | We may never achieve long-term global herd immunity for COVID. But if we’re all vaccinated, we’ll be safe from the worst appeared first on Links Medicus.
What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest
mercredi, 05 mai 2021 14:40 Écrit par Zouhair SouissiWhat’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest – Science
The post What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest appeared first on Links Medicus.
![[Preprint] SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity](/media/k2/items/cache/bd5b551e7d6b7885a6be84801d23aa11_M.jpg)
[Preprint] SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity
mercredi, 05 mai 2021 14:40 Écrit par Zouhair SouissiSARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity – medRxiv Commentary: SARS-CoV-2 antibodies are detectable up to a year after infection, finds study – News Medical Commentary on Twitter Ahhh… A year has passed since people with Covid-19 were enrolled in a longitudinal study […]
The post [Preprint] SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity appeared first on Links Medicus.
Novel coronavirus really is seasonal, study suggests
mardi, 04 mai 2021 14:13 Écrit par Zouhair SouissiNovel coronavirus really is seasonal, study suggests – LiveScience Original study: Climate and the spread of COVID-19 – Scientific Reports
The post Novel coronavirus really is seasonal, study suggests appeared first on Links Medicus.
Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose
mardi, 04 mai 2021 14:13 Écrit par Zouhair SouissiPrior SARS-CoV-2 infection boosts response to variants after first vaccine dose – Imperial College London Original study: Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose – Science Commentary on Twitter (thread – click for more) Just published @ScienceMagazine "After one dose, individuals with *prior infection* showed enhanced […]
The post Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose appeared first on Links Medicus.
M-A: Prone positioning of nonintubated patients with Covid-19 improve oxygenation variables without any reported serious adverse events – randomized trials with patient-relevant outcomes such as the need for intubation or mortality rates are required
mardi, 04 mai 2021 14:13 Écrit par Zouhair SouissiProne Positioning of Nonintubated Patients With Coronavirus Disease 2019—A Systematic Review and Meta-Analysis – Critical Care Medicine (link to abstract – $ for full-text)
The post M-A: Prone positioning of nonintubated patients with Covid-19 improve oxygenation variables without any reported serious adverse events – randomized trials with patient-relevant outcomes such as the need for intubation or mortality rates are required appeared first on Links Medicus.
![[Preprint] Preventing disproportionate mortality in ICU overload situations: Empirical evidence from the first COVID-19 wave in Europe – “transferring patients proactively out of developing hotspots to less affected regions, well before high ICU workload](/media/k2/items/cache/a906ecd58b062801ef8efce6e1a38d4d_S.jpg)
[Preprint] Preventing disproportionate mortality in ICU overload situations: Empirical evidence from the first COVID-19 wave in Europe – “transferring patients proactively out of developing hotspots to less affected regions, well before high ICU workload
mardi, 04 mai 2021 10:46 Écrit par Zouhair SouissiPreventing disproportionate mortality in ICU overload situations: Empirical evidence from the first COVID-19 wave in Europe – medRxiv
The post [Preprint] Preventing disproportionate mortality in ICU overload situations: Empirical evidence from the first COVID-19 wave in Europe – “transferring patients proactively out of developing hotspots to less affected regions, well before high ICU workload situations emerge, will improve patient outcomes” appeared first on Links Medicus.
